Lambda Therapeutics Research Ltd (LTRL)
Ahmedabad, Near Gujrat High Court, SG Highway, Gota, 380 061 Gujrat, India
NCT Number: NCT02814357
Double-blind, randomized, controlled, cross-over design with 3 test products and one control product.
To evaluate the effect of 4 different flour compositions (guar gum 2% and 4%, chickpea flour 15% and barley flour 2% and 5%) of selected fibres and flours, on post-prandial plasma (PPG) and serum insulin levels in healthy Indian subjects, after the consumption of flat bread made from 100 gram of flour compositions.
Looking for future studies?
Notify Me20 year–50 year
All sexes
Interventional
Not applicable
Ahmedabad, Near Gujrat High Court, SG Highway, Gota, 380 061 Gujrat, India
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 0-120 minutes
Time frame: 0-120 minutes
Time frame: 0-120 minutes
Time frame: 0-120 minutes
Time frame: 0-120 minutes
Time frame: 180 minutes
Time frame: 180 minutes
Time frame: 0-180 minutes
Time frame: 0-120 minutes
Unilever R&D
Industry
To Evaluate the Effect of 4 Different Flour Compositions of Selected Fibres and Flours, on Post-prandial Plasma Glucose (PPG) and Serum Insulin Levels in Normal Indian Healthy Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07232732
Body Weight, Healthy
Daytona Beach, Florida, United States
View Trial DetailsNCT07781618
Healthy
Bruges, West-Flanders, Belgium
View Trial DetailsNCT04606979
Basal Ganglia Diseases, Brain Diseases
Brussels, Brussels Capital, Belgium
View Trial DetailsNCT05804344
Healthy
New York, United States
View Trial Details